HPS2503-95
2022956-58-5
默认>95%HPLC，若需其他规格请洽询
| 产品编号 | 规格 | 货期 | 销售价 | 折扣价 | 数量 | 操作 |
|---|---|---|---|---|---|---|
| HPS2503-95 | 默认>95%HPLC，若需其他规格请洽询 |
25天
|
敬请询价 | 敬请询价 |
 
|
| 名字 | Biotinyl-Tau Peptide (306-336) (Repeat 3 Domain) (human) trifluoroacetate salt |
|---|---|
| 序列(三字母) | Biotinyl-Val-Gln-Ile-Val-Tyr-Lys-Pro-Val-Asp-Leu-Ser-Lys-Val-Thr-Ser-Lys-Cys-Gly-Ser-Leu-Gly-Asn-Ile-His-His-Lys-Pro-Gly-Gly-Gly-Gln-OH trifluoroacetate salt |
| 序列(单字母) | Biotinyl-VQIVYKPVDLSKVTSKCGSLGNIHHKPGGGQ |
| CAS# | 2022956-58-5 |
| 分子式 | C₁₅₃H₂₅₀N₄₄O₄₄S₂ |
| 分子量 | 3474.07 |
| 纯度 | 默认>95%HPLC，若需其他规格请洽询 |
| 合成方法 | Synthetic |
| 储存条件 | -20 ± 5 °C |
| 应用 | Biotinylated Peptides|Tau Peptides |
| 描述 | The amphipathic helical structure of the third fragment (306-336), in the four-repeat microtubule-binding domain of tau, is hypothesized to be responsible for the formation of the neuropathological filament. The additional biotin moiety will bind avidin or streptavidin with high specificity and affinity, providing robust results. |
